Last reviewed · How we verify

NCT03897426

Image Based Mobile System for Dietary Assessment and Coaching

Completed NA Last updated 2 April 2019
What this trial tests

NA trial testing Mediterranean Diet - Remote Coaching using a Mobile App in Cardiovascular Diseases in 100 participants. Completed in 31 August 2017.

Timeline
4 March 2016
Primary endpoint
2 June 2017
31 August 2017

Quick facts

Lead sponsorVibrent Health
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment100
Start date4 March 2016
Primary completion2 June 2017
Estimated completion31 August 2017

Drugs / interventions tested

Conditions studied

Sponsor

Vibrent Health

Who can join

Adults 21 to 75, any sex, with Cardiovascular Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Vignet partnered with The George Washington University Hospital to conduct a randomized control trial (RCT) with to evaluate the system's potential to improve health outcomes for patients with CVD. Results from the RCT have the potential to be applied to patients in other chronic disease contexts.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Image-Based Mobile System for Dietary Management in an American Cardiology Population: Pilot Randomized Controlled Trial to Assess the Efficacy of Dietary Coaching Delivered via a Smartphone App Versus Traditional Counseling.
    Choi BG, Dhawan T, Metzger K, Marshall L, et al · · 2019 · cited 33× · PMID 31012860 · DOI 10.2196/10755

Verify or expand the search:

Other recruiting trials for Cardiovascular Diseases

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03897426.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing